Strs Ohio Has $16.50 Million Stock Position in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Strs Ohio boosted its stake in Sabra by 1,916.2% in Q4 to 871,000 shares—about $16.5 million, or 0.35% of the company.
• Q1 results beat revenue and FFO estimates and Sabra raised FY‑2026 EPS guidance to $1.55–$1.59, while declaring a $0.30 quarterly dividend (≈5.9% yield); however, the dividend payout ratio is ~190% and management said it will revisit guidance after ~$400M of year‑to‑date investments, raising sustainability concerns.
• Analyst view is a consensus "Moderate Buy" with a $22 target after recent upgrades and price‑target increases from several firms (Citigroup, Wells Fargo, Cantor Fitzgerald, UBS).

Strs Ohio increased its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 1,916.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 871,000 shares of the real estate investment trust's stock after buying an additional 827,800 shares during the period. Strs Ohio owned 0.35% of Sabra Healthcare REIT worth $16,497,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Founders Capital Management bought a new stake in shares of Sabra Healthcare REIT during the 3rd quarter worth $28,000. Danske Bank A S bought a new stake in shares of Sabra Healthcare REIT during the 3rd quarter worth $30,000. Larson Financial Group LLC boosted its holdings in shares of Sabra Healthcare REIT by 42.3% during the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust's stock worth $35,000 after buying an additional 553 shares during the period. First Horizon Corp bought a new stake in shares of Sabra Healthcare REIT during the 4th quarter worth $44,000. Finally, Covestor Ltd boosted its holdings in shares of Sabra Healthcare REIT by 23,720.0% during the 3rd quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust's stock worth $45,000 after buying an additional 2,372 shares during the period. 99.40% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

SBRA has been the subject of several recent analyst reports. Cantor Fitzgerald upped their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a "neutral" rating in a report on Tuesday, February 17th. Wall Street Zen raised shares of Sabra Healthcare REIT from a "sell" rating to a "hold" rating in a report on Saturday. Citigroup upped their price objective on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a "buy" rating in a report on Wednesday, February 18th. Wells Fargo & Company increased their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company an "overweight" rating in a report on Thursday, March 26th. Finally, UBS Group increased their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a "neutral" rating in a report on Thursday, February 19th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $22.00.

Sabra Healthcare REIT Price Performance

NASDAQ:SBRA opened at $20.36 on Monday. The company has a 50-day moving average of $20.23 and a 200-day moving average of $19.36. The company has a market capitalization of $5.13 billion, a price-to-earnings ratio of 32.32, a PEG ratio of 1.63 and a beta of 0.67. Sabra Healthcare REIT, Inc. has a 52 week low of $17.04 and a 52 week high of $21.07. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting analysts' consensus estimates of $0.16. The company had revenue of $221.75 million during the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The firm's revenue for the quarter was up 20.9% compared to the same quarter last year. During the same period last year, the firm earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, equities research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 29th. Stockholders of record on Friday, May 15th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.9%. The ex-dividend date of this dividend is Friday, May 15th. Sabra Healthcare REIT's dividend payout ratio (DPR) is presently 190.48%.

Key Sabra Healthcare REIT News

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Q1 top‑line and FFO beat — Sabra reported revenue of $221.8M (above estimates) and FFO of $0.39, beating consensus ($0.38), showing continued SHOP/senior‑housing contribution and improved cash flow dynamics. Sabra Healthcare (SBRA) Tops Q1 FFO and Revenue Estimates
• Positive Sentiment: FY‑2026 guidance nudged higher — company set EPS guidance of $1.55‑$1.59 vs. consensus ~1.50, implying modest upside to street earnings expectations. Press Release / Slide Deck
• Positive Sentiment: Dividend declared — quarterly dividend of $0.30/share (annualized yield ~5.8%), supporting income investor interest. (Company release)
• Positive Sentiment: Analyst support — at least one published note sets a $22 price target, indicating some analyst optimism on valuation upside. Analysts Set Sabra Healthcare REIT, Inc. NASDAQ: SBRA Price Target at $22.00
• Neutral Sentiment: SHOP/senior‑housing contribution highlighted — management and coverage note this was a driver of the quarter, an operational detail investors should watch for sustainability. Sabra Showcases Strong SHOP‑Driven Quarter
• Neutral Sentiment: Earnings metrics mixed — GAAP EPS of $0.16 met estimates but remains below last year’s quarter (affected by mix and non‑recurring items); slides and full call transcript are available for detail. Earnings Call Transcript / Presentation Q1 Presentation
• Negative Sentiment: Guidance subject to review — management said it will “revisit” 2026 guidance in Q2 after year‑to‑date investments of ~$400M, creating near‑term uncertainty about capital allocation and payout sustainability. Sabra Outlines Revisiting 2026 Guidance
• Negative Sentiment: Tighter deal flow and competition — CEO warned skilled‑nursing acquisition activity is tight and competition from private OpCo/PropCo buyers is fierce, which may limit attractive deployment opportunities and pressure future growth. CEO: Skilled Nursing Deal Flow Tight

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc NASDAQ: SBRA is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra's tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.